MICHAEL WOUDENBERG - 05 Dec 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Chief Operating Officer
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg
Issuer symbol
INM
Transactions as of
05 Dec 2023
Net transactions value
$0
Form type
4
Filing time
06 Dec 2023, 09:02:25 UTC
Previous filing
19 Dec 2022
Next filing
26 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -848 -7.5% $0.000000 10,494 05 Dec 2023 Common shares 848 $270.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$367.125 using an exchange rate of C$1.3579 = $US1.00